Ergoteles LLC Oramed Pharmaceuticals Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $922,534 - $1.99 Million	-200,551 Reduced 89.25%	24,149 $156,000
Q2 2022 Aug 12, 2022	BUY	$3.72 - $9.0 $835,884 - $2.02 Million	224,700 New	224,700 $1.03 Million
Q1 2022 May 13, 2022	SELL	$8.19 - $13.89 $276,822 - $469,482	-33,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $438,724 - $1.01 Million	33,800 New	33,800 $483,000

6.37M

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $93.6M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.